Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.

New York Stock Exchange ArcaETF
$39.2499
−$0.2039 · -0.52%
As of Oct 8, 2:35 PM ET
Regular session · ET · Market data may be delayed.
This actively managed exchange-traded fund, known as the YieldMax MRNA Option Income Strategy ETF (MRNY), is engineered to deliver consistent weekly income. It achieves this by strategically issuing call options or initiating call spreads that are tied to shares of MRNA. The fundamental design of this approach is to collect premiums from these options, while also providing investors with a means to participate in any upward movement in MRNA's stock valuation.
Fund facts updated Oct 7, 2026.
Day range
Current $39.2499
52-week range
Current $39.2499
1 month
+20.81%
3 months
+98.13%
Year to date
+167.01%
1 year
+111.02%
Since inception
-80.38%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 15 of 15 reported holdings
Holdings data updated Oct 8, 2026.
Oct 8, 2026
Oct 8, 2026
Oct 9, 2026
$0.7462
Weekly
Oct 1, 2026
Oct 1, 2026
Oct 2, 2026
$0.8073
Weekly
Sep 24, 2026
Sep 24, 2026
Sep 25, 2026
$0.6367
Weekly
Sep 17, 2026
Sep 17, 2026
Sep 18, 2026
$0.5672
Weekly
Sep 10, 2026
Sep 10, 2026
Sep 11, 2026
$0.642
Weekly
Sep 3, 2026
Sep 3, 2026
Sep 4, 2026
$0.6373
Weekly
Aug 27, 2026
Aug 27, 2026
Aug 28, 2026
$0.8925
Weekly
Aug 20, 2026
Aug 20, 2026
Aug 21, 2026
$0.2261
Weekly
Aug 13, 2026
Aug 13, 2026
Aug 14, 2026
$0.2216
Weekly
Aug 6, 2026
Aug 6, 2026
Aug 7, 2026
$0.2038
Weekly
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.